Planning and performance of high-resolution mass spectrometry investigations in
Analytical Research to characterize impurities, metabolites, and research compounds Performance of structure elucidation studies with LC-MS, including sample preparation, performance of measurements, data processing and reporting
Development of LC-UV-MS and MS/MS methods including data evaluation procedures
Deliver concise results summaries according to the established reporting processes
Closely work with other scientists to discuss results and data reporting
Your profile
Master or Bachlor Degree in Chemistry/Pharmacy or equivalent
Minimum of 1-3 years relevant industry experience with a strong background in organic chemistry
Profound knowledge in mass spectrometry and chromatographic separations of small molecules, know-how of structure elucidation with mass spectrometry is considered an advantage
Excellent computer skills (especially good knowledge in the use of analytical software tools)
Acceptant to work according to established laboratory rules, knowledge in GLP and/or
cGMP is desirable Ability to work both independently and collaboratively in a team environment with a
high level of integrity Structured and accurate way of working with excellent analytical skills and attention to detail
Project and customer-oriented personality
Good communication, presentation and reporting skills in English
Why us?
Basilea is committed to putting people first. In addition to competitive remuneration, we offer the opportunity to work on inspiring, cross-functional projects in an engaging working environment. We strongly believe that every employee can make an impact and is vital to our success.
If you wish to become part of a company that strives to make a difference to the lives of patients worldwide, we are looking forward to receiving your application via our careers portal.
Additional information can be found on our website www.basilea.com.
Apply for this job
About us
Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. Basilea has about 150 employees. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial or fungal infections. We have successfully launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of bacterial infections. In addition, we have preclinical anti-infective assets in our portfolio. Basilea is listed on the SIX Swiss Exchange (SIX: BSLN).
Beware of fraud agents! do not pay money to get a job
MNCJobs.ch will not be responsible for any payment made to a third-party. All Terms of Use are applicable.